ARCHIVES

Partial Responses To Zactima In Thyroid Cancer Trial

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Funding Opportunities: NCI Seeks SBIR Applicants For Research On Detection Assays

July 3, 1998

Thomas Tomasi Named New Director Of Roswell Park

June 27, 1986

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002